Last checked at 7 Dec 2020 15:37
Ap19
FORM 8.3 - Amendment to Purchase & Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 02 December 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
3,041,564 | 2.36% | 609,540 | 0.47% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
285,211 | 0.22% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,326,775 | 2.58% | 1,348,545 | 1.05% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 2 | 214.7200 USD |
Purchase | 13 | 212.7169 USD |
Purchase | 14 | 212.5019 USD |
Purchase | 15 | 213.1110 USD |
Purchase | 16 | 213.0581 USD |
Purchase | 18 | 212.9719 USD |
Purchase | 18 | 212.9716 USD |
Purchase | 20 | 213.1620 USD |
Purchase | 21 | 212.9478 USD |
Purchase | 21 | 215.2100 USD |
Purchase | 22 | 212.5909 USD |
Purchase | 23 | 213.0128 USD |
Purchase | 27 | 212.9100 USD |
Purchase | 31 | 213.1153 USD |
Purchase | 60 | 213.6800 USD |
Purchase | 92 | 212.4150 USD |
Purchase | 100 | 212.3700 USD |
Purchase | 100 | 213.9200 USD |
Purchase | 115 | 215.3223 USD |
Purchase | 120 | 215.2766 USD |
Purchase | 126 | 212.7595 USD |
Purchase | 141 | 212.4093 USD |
Purchase | 222 | 211.9675 USD |
Purchase | 230 | 212.5527 USD |
Purchase | 238 | 212.9391 USD |
Purchase | 239 | 213.6813 USD |
Purchase | 258 | 212.5341 USD |
Purchase | 267 | 215.2318 USD |
Purchase | 272 | 212.7394 USD |
Purchase | 288 | 213.0338 USD |
Purchase | 384 | 212.8770 USD |
Purchase | 396 | 213.5560 USD |
Purchase | 400 | 212.9316 USD |
Purchase | 416 | 212.8180 USD |
Purchase | 517 | 212.8305 USD |
Purchase | 517 | 215.3776 USD |
Purchase | 574 | 215.4842 USD |
Purchase | 685 | 212.5865 USD |
Purchase | 1,075 | 212.6502 USD |
Purchase | 1,171 | 215.2917 USD |
Purchase | 2,260 | 212.6221 USD |
Purchase | 4,106 | 212.6730 USD |
Purchase | 4,463 | 212.8202 USD |
Purchase | 4,565 | 212.5250 USD |
Purchase | 7,775 | 212.4900 USD |
Purchase | 15,662 | 212.9133 USD |
Sale | 1 | 214.5200 USD |
Sale | 1 | 212.5400 USD |
Sale | 1 | 215.2800 USD |
Sale | 3 | 213.7550 USD |
Sale | 7 | 212.3900 USD |
Sale | 7 | 212.9685 USD |
Sale | 9 | 212.7866 USD |
Sale | 10 | 212.9200 USD |
Sale | 72 | 215.0800 USD |
Sale | 123 | 212.5534 USD |
Sale | 132 | 212.2248 USD |
Sale | 200 | 214.1800 USD |
Sale | 201 | 212.5101 USD |
Sale | 210 | 215.3076 USD |
Sale | 393 | 212.5205 USD |
Sale | 476 | 212.9391 USD |
Sale | 478 | 212.9700 USD |
Sale | 685 | 212.5865 USD |
Sale | 1,049 | 213.3874 USD |
Sale | 1,669 | 212.4897 USD |
Sale | 2,376 | 212.7322 USD |
Sale | 2,785 | 215.3416 USD |
Sale | 2,797 | 212.9479 USD |
Sale | 3,420 | 212.6453 USD |
Sale | 4,288 | 212.6370 USD |
Sale | 6,000 | 212.7315 USD |
Sale | 6,291 | 212.4900 USD |
Sale | 12,932 | 212.8323 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing |
| and any other person relating to the voting rights of any relevant securities under any option |
| referred to on this form or relating to the voting rights or future acquisition or disposal of any |
| relevant securities to which any derivative referred to on this form is referenced. If none, this |
| should be stated. |
| NONE |
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 7 Dec 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201207005682/en/
Copyright Business Wire 2020